Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lucentis
Pharma
Italy opens antitrust case against Novartis, Biogen and others
Italy's antitrust agency is going after several companies for allegedly delaying the launch of a Lucentis biosimilar in Italy.
Zoey Becker
Jun 6, 2024 11:39am
Appeals court backs Regeneron's antitrust suit against Novartis
Mar 19, 2024 10:40am
Sandoz buys Coherus' Lucentis biosimilar Cimerli for $170M
Jan 22, 2024 11:55am
Novartis targets Xiidra in eye disease asset sale: Bloomberg
Mar 14, 2023 10:22am
Novartis, Roche avoid $475M fine in French appeals court
Feb 17, 2023 11:41am
Novartis targets eye, respiratory units for sell-offs: Bloomberg
Nov 16, 2022 10:48am
